EUR 0.04
(7.69%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 481.72 Thousand AUD | 441.3% |
2023 | 88.99 Thousand AUD | 100.31% |
2022 | 349.18 Thousand AUD | 547.29% |
2021 | -78.06 Thousand AUD | -108.09% |
2020 | 965.13 Thousand AUD | 0.0% |
2019 | 965.13 Thousand AUD | 295.75% |
2018 | 243.87 Thousand AUD | 223.71% |
2017 | -197.13 Thousand AUD | -247.16% |
2016 | -56.78 Thousand AUD | 0.0% |
2015 | - AUD | 0.0% |
2014 | - AUD | 0.0% |
2013 | - AUD | 0.0% |
2012 | - AUD | 0.0% |
2011 | - AUD | 0.0% |
2010 | - AUD | 0.0% |
2009 | - AUD | 0.0% |
2008 | - AUD | 0.0% |
2007 | - AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -107.7 Thousand EUR | 0.0% |
2024 Q4 | -51.39 Thousand EUR | 0.0% |
2023 FY | 699.44 Thousand AUD | 100.31% |
2023 Q4 | 82.9 Thousand EUR | 378.35% |
2023 Q2 | -29.78 Thousand EUR | 62.35% |
2022 Q2 | -75.85 Thousand EUR | -220.5% |
2022 Q4 | -79.11 Thousand EUR | -4.3% |
2022 FY | 349.18 Thousand AUD | 547.29% |
2021 FY | -78.06 Thousand AUD | -108.09% |
2021 Q4 | 62.95 Thousand EUR | 168.65% |
2021 Q2 | 23.43 Thousand EUR | 186.79% |
2020 Q2 | -122.54 Thousand EUR | 63.56% |
2020 Q4 | -27 Thousand EUR | 77.97% |
2020 FY | 965.13 Thousand AUD | 0.0% |
2019 Q4 | -336.28 Thousand EUR | 0.0% |
2019 FY | 965.13 Thousand AUD | 295.75% |
2018 FY | 243.87 Thousand AUD | 223.71% |
2017 FY | -197.13 Thousand AUD | -247.16% |
2016 FY | -56.78 Thousand AUD | 0.0% |
2015 FY | - AUD | 0.0% |
2014 FY | - AUD | 0.0% |
2013 FY | - AUD | 0.0% |
2012 FY | - AUD | 0.0% |
2011 FY | - AUD | 0.0% |
2010 FY | - AUD | 0.0% |
2009 FY | - AUD | 0.0% |
2008 FY | - AUD | 0.0% |
2007 FY | - AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
DocCheck AG | 12.97 Million EUR | 96.287% |
CompuGroup Medical SE & Co. KGaA | 374.5 Million EUR | 99.871% |
MeVis Medical Solutions AG | 7 Million EUR | 93.121% |
Nexus AG | 65.97 Million EUR | 99.27% |